No photo available yet
Agilent Technologies BL21(DE3) Chemically Competent Cells for protein expression
Agilent Technologies BL21(DE3) Chemically Competent Cells for protein expression — Protein expression.
BL21(DE3) chemically competent cells are a T7 RNA polymerase-based E. coli expression host supplied in a transformation-ready format. The DE3 lysogen carries the T7 polymerase gene under lacUV5 control, so target genes cloned behind a T7 promoter are induced with IPTG. This modification is the standard host for general protein expression; the facts provided do not specify a transformation efficiency for this exact model.
Full specifications
| Aav Gene Delivery Efficiency | 90 % |
| Aav Maximum Insert Size | 3 kb |
| Adeasy Maximum Insert Size | 7.5 kb |
| Adeasy Xl Gene Delivery Efficiency | 90 % |
| Quikchange Ht Mutational Region | 50 AA |
| Quikchange Lightning Multi Thermocycling Time Reduction | 75 % |
| Surevector Assembly Reaction Time | 20 min |
| Surevector Time To New Vector | 1 day |
| QuikChange HT oligos per reaction mfr | 950 oligos |
| SURE 2 Supercompetent cells transformation efficiency mfr | 1 cfu/μg |
| SURE Electroporation Competent cells transformation efficiency mfr | 1 cfu/μg |
| SURE Competent cells transformation efficiency mfr | 5 cfu/μg |
| ABLE K Competent cells transformation efficiency mfr | 5 cfu/μg |
| TG1 Competent cells transformation efficiency mfr | 1 cfu/μg |
| XL10-Gold Ultracompetent cells transformation efficiency mfr | 5 cfu/μg |
| ElectroTen-Blue Electroporation Competent cells transformation efficiency mfr | 3 cfu/μg |
| SoloPack Gold Supercompetent cells transformation efficiency mfr | 1 cfu/μg |
| SoloPack Gold Competent cells transformation efficiency mfr | 1 cfu/μg |
| XL1-Blue Electroporation Competent cells transformation efficiency mfr | 10 cfu/μg |
| XL2-Blue Ultracompetent cells transformation efficiency mfr | 5 cfu/μg |
| BL21-CodonPlus (DE3)RIPL Competent cells transformation efficiency mfr | 1 cfu/μg |
| Transformation efficiency mfr | 1 |
| ABLE K Strain mfr | 15 |
| BL21 Strain mfr | E. coli B F– dcm ompT hsdS gal gal |
| BL21(DE3) Strain mfr | E. coli B F– dcm ompT hsdS gal λ |
| BL21(DE3)pLysS Strain mfr | E. coli B F– dcm ompT hsdS gal λ [pLysS Camr]* |
| BL21-CodonPlus (DE3)-RIPL Strain mfr | E. coli B F– ompT hsdS dcm+ Tetr gal λ endA Hte |
| ElectroTen-Blue Strain mfr | 183 |
| JM101 Strain mfr | -1 |
| JM109 Strain mfr | 14 |
| JM110 Strain mfr | -1 |
| SCS1 Strain mfr | 1 |
| SCS110 Strain mfr | -1 |
| TG1 Strain mfr | -1 |
| XL1-Blue Strain mfr | 1 |
| XL1-Blue MR Strain mfr | 183 lac |
| XL1-Blue MRF' Strain mfr | 183 |
| XL2-Blue Strain mfr | 1 |
| XL2-Blue MRF' Strain mfr | 183 |
| XL1-Red Strain mfr | 1 |
| Subcloning-grade transformation efficiency mfr | 1 ransformants/μg |
| Competent cell transformation efficiency mfr | 1 ransformants/μg |
| Supercompetent cell transformation efficiency mfr | 1 ransformants/μg |
| Ultracompetent cell transformation efficiency mfr | 5 ransformants/μg |
| Electroporation-competent cell transformation efficiency mfr | 1 ransformants/μg |
| ElectroTen-Blue transformation efficiency mfr | 3.0 |
| SURE electroporation-competent transformation efficiency mfr | 1 DNA |
| SURE competent-grade transformation efficiency mfr | 5 DNA |
| SURE2 supercompetent transformation efficiency mfr | 1 DNA |
| ABLE K plasmid copy number reduction mfr | 10 fold |
| XL1-Red mutation rate increase mfr | 5000 higher |
| BL21-Gold Starin mfr | E. coli B F– dcm+ Hte ompT hsdS gal endA Tetr a |
| BL21-Gold(DE3) Strain mfr | E. coli B F– dcm+ Hte ompT hsdS gal λ endA Tetr |
| BL21-Gold(DE3)pLysS Strain mfr | E. coli B F– dcm+ Hte ompT hsdS gal λ [pLysS Cam |
| BL21-CodonPlus RIL Strain mfr | E. coli B F– ompT hsdS dcm+ Tetr gal endA Hte [a |
| BL21-CodonPlus(DE3)-RIL Strain mfr | E. coli B F– ompT hsdS dcm+ Tetr gal λ endA Hte |
| BL21-CodonPlus (DE3)-RP Strain mfr | E. coli B F– ompT hsdS dcm+ Tetr gal λ endA Hte |
| Standard Transfection Gene Delivery Efficiency | 20 % |
Description
Construction and series positioning
- BL21(DE3) is a chemically competent E. coli host carrying the DE3 prophage, which places T7 RNA polymerase under control of the lacUV5 promoter; expression is therefore IPTG-inducible.
- Within the Agilent competent cell portfolio the BL21(DE3) line sits alongside BL21, BL21-Gold, BL21-CodonPlus (RIL/RP/RIPL) and pLysS derivatives; the pLysS and CodonPlus variants add control or rare-tRNA supplementation, while this base DE3 host is the general-purpose choice.
- The supplied facts do not include a verified transformation efficiency for this exact model; the 5 cfu/µg figure in the extra specs is unlabeled and must not be attributed to BL21(DE3).
Behaviour and use
- Because T7 polymerase is under lacUV5 control, target genes must be cloned downstream of a T7 promoter; induction is by IPTG addition.
- The provided document digests contain no growth, induction or yield data for this model, so no temperature, OD or incubation figures are stated here.
Handling and operation
- The attached brochures are portfolio-level leaflets and contain no actionable protocol facts (no transformation procedure, heat-shock conditions, recovery medium or storage temperatures); consult the product-specific protocol before use.
Integration & Operating Notes
The DE3 lysogen supplies T7 RNA polymerase under lacUV5 control, so only constructs with a T7 promoter are transcribed by this host; genes on other promoters will not be expressed through the T7 route and require a different host or promoter design.
Expression is triggered by IPTG, which is listed in the portfolio as an accessory rather than part of the base cell delivery; plan to source IPTG separately and to define the induction point in your protocol, since the supplied digests give no induction parameters.
The attached documents are portfolio leaflets with no transformation, heat-shock, recovery or storage instructions. Obtain the lot-specific protocol for this model before first use, because the digests provide no actionable handling facts to rely on.
The extra specification list contains an unlabeled transformation efficiency value of 5 alongside many strain-specific entries. No efficiency is verified for BL21(DE3) itself, so qualification of a lot should be based on the certificate supplied with the cells, not on that table.
Selection & Integration Q&A
Pick base BL21(DE3) for routine T7-driven expression when no rare-codon supplementation or extra stringency is needed. BL21-CodonPlus (RIL/RP/RIPL) adds rare tRNAs for codon-biased genes; pLysS derivatives add tighter control of basal T7 expression. The supplied facts give no efficiency data to rank them numerically.
The gene must be cloned downstream of a T7 promoter, since the DE3 lysogen supplies T7 polymerase under lacUV5 control. IPTG is required for induction and is listed as a separate accessory, not part of the base cell delivery, so it must be sourced and its addition point defined in your protocol.
The attached brochures are portfolio-level leaflets and contain no transformation, heat-shock, recovery or storage temperatures for this model. The lot-specific product protocol must be obtained and followed; no handling limits can be quoted from the supplied digests.
IPTG and AMP Tabs appear in the portfolio as accessories rather than base-delivery items, so induction and selection reagents should be ordered separately. No transformation-efficiency value is verified for this exact model, so lot qualification should rely on the supplied certificate.